// App-Quantinova.ai

TCT-317 : Impact of Coronary Artery Dominance on Prognosis After PCI and CABG for Unprotected Left Main Disease: Analysis From the EXCEL Trial

Researchers

Presenter

  • Eisuke Usui

Principal Investigators

  • Akiko Maehara

  • Masahiko Noguchi

  • Tatsuhiro Fujimura

  • Fotios Gkargkoulas

  • Ziad Ali

  • Yiran Zhang

  • A. Pieter Kappetein

  • Joseph Sabik

  • Patrick Serruys

  • Gary Mintz

  • Philippe Genereux

  • Gregg Stone

Medical Centers

  • Imperial College, London, United Kingdom

  • Cardiovascular Research Foundation, New York, New York, USA

  • Medtronic, Mounds View, Minnesota

  • Cardiovascular Research Foundation, Columbia University Medical Center/New York–Presbyterian Hospital, New York, New York

  • New York–Presbyterian Hospital/Columbia University Medical Center, New York, New York

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

  • Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Left main disease

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved